www.statnews.com Open in urlscan Pro
2606:4700::6812:1ccd  Public Scan

Form analysis
3 forms found in the DOM

GET https://www.statnews.com/

<form class="header-search search-form" role="search" method="get" action="https://www.statnews.com/">
  <input type="search" class="search-form-field" placeholder="Search …" value="" name="s" aria-label="Search …">
  <button type="submit" class="header-btn header-btn-search">Search</button>
</form>

Name: page — POST /wp-json/stat-hubspot/v1/signup

<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="page">
  <div class="stat-hubspot-signup-fields">
    <div class="stat-form-inline" data-stat-newsletter-no-step-2="">
      <div class="stat-form-full">
        <input type="email" name="email" placeholder="Email Address" aria-label="Enter your email" required="">
        <div class="stat-field-error">Please enter a valid email address.</div>
        <input type="submit" value="Sign Up">
        <input type="hidden" name="stat_newsletters_source" value="homepage_widget">
        <input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
      </div>
      <div class="stat-form-full stat-form-checkbox-wrapper">
        <input type="checkbox" name="marketing_opt_in" id="marketing" value="1">
        <label for="marketing">I'd like to be emailed about new content, events, and products.</label>
      </div>
    </div>
  </div>
  <div class="stat-hubspot-signup-response"></div>
</form>

Name: default — POST /wp-json/stat-hubspot/v1/signup

<form class="stat-hubspot-signup stat-form" method="post" action="/wp-json/stat-hubspot/v1/signup" name="default">
  <div class="stat-hubspot-signup-fields">
    <input type="email" name="email" placeholder="Enter your email" aria-label="Enter your email" required="">
    <button class="stat-arrow-submit" aria-label="Submit">
      <span class="far fa-arrow-right" aria-hidden="true"></span>
    </button>
    <input type="hidden" name="stat_newsletters_source" value="footer_bar">
    <input type="hidden" name="stat_newsletters_campaign" value="">
    <input type="hidden" name="lists[stat_newsletters]" value="morning_rounds">
  </div>
  <div class="stat-hubspot-signup-response"></div>
</form>

Text Content

Skip to Main Content
Explore what it takes to make the health care system work.
research
Cancer
campaigns
Sign up for 25% off your next STAT Report
 * Newsletters
 * Log In
 * My Account
 * Subscribe Now

My Account
 * Settings
 * Billing
 * Log In

Reporting from the frontiers of health and medicine
 * Newsletters
 * Log In
 * My Account
 * Subscribe Now

 * Biotech
 * Pharma
 * Public Health
 * Health Tech
 * Policy
 * Science
 * First Opinion
 * STAT+
 * STAT Events
 * 


Search
 * Log In
 * Subscribe Now
 * My Account

Home

News
 * Latest
 * Business
   * Biotech
   * Pharma
   * Health Tech
   * Health Insurance
   * Hospitals
   * Medical Devices
 * Washington
   * Policy
   * FDA
   * CDC
   * NIH
 * Science
   * CRISPR
   * Gene Therapy
   * Research
   * Neuroscience

 * Public Health
   * H5N1 Bird Flu
   * Addiction
   * Covid-19
   * Abortion
   * Health Disparities
   * Infectious Disease
   * Mental Health
 * Disease
   * Cancer
   * Cardiovascular Disease
   * Chronic Disease
   * Diabetes
   * Alzheimer's
   * Obesity
 * Features
   * Coercive Care
   * The Obesity Revolution
   * The War on Recovery

Newsletters
Opinion
Columns
 * Adam Feuerstein
 * Matthew Herper
 * Jennifer Adaeze Okwerekwu
 * Ed Silverman

Reports
E-books
Podcasts
Tools & Trackers
 * CRISPR Tracker
 * Breakthrough Device Tracker
 * Generative AI Tracker
 * Obesity Drug Tracker

Events
 * 2024 STAT Summit

Community
 * Wunderkinds Nomination
 * STAT Madness

Video
Advertise
 * STAT Brand Studio

Don't miss out

Subscribe to STAT+ today, for the best life sciences journalism in the industry

Learn more


STAT — REPORTING FROM THE FRONTIERS OF HEALTH AND MEDICINE


LATEST

 * 14 hr ago
   
   STAT PLUS: PARASITE ENGINEERED TO TREAT BRAIN DEVELOPMENT DISORDER IN MICE
   SHOWS POTENTIAL IN STUDY

 * 15 hr ago
   
   
   DATING APP GRINDR HIRES TOM DASCHLE’S FIRM TO LOBBY ON HIV PREVENTION, IVF

 * 18 hr ago
   
   
   MORNING ROUNDS: WOULD A BIRD FLU VACCINE FOR COWS WORK?

 * 
 * 19 hr ago
   
   
   BLOOD TESTS FOR ALZHEIMER’S DIAGNOSIS WERE 91% ACCURATE IN NEW STUDY

 * 19 hr ago
   
   
   NEW CARDIOVASCULAR RISK MODEL COULD GREATLY DECREASE USE OF STATINS AND
   INCREASE HEART ATTACKS, STUDY WARNS

 * 20 hr ago
   
   STAT PLUS: IN A BIG STEP FOR LIQUID BIOPSY, FDA APPROVES A BLOOD SCREENING
   TEST FOR COLORECTAL CANCER

More Stories


DON'T MISS

For decades, physicians have steered sickle cell patients toward sterilization

Explore the series


TOP STORIES

Health tech

STAT PLUS: HEALTH CARE’S ‘PEPSI CHALLENGE’: DOCTORS’ OFFICES ARE TESTING AI
TOOLS IN HEAD-TO-HEAD PILOTS

A half-dozen companies dominate AI scribe contracts with health systems,
including Microsoft’s Nuance, Nabla, and Epic-partnered Abridge.

By Katie Palmer

1 hr ago

 * Artificial intelligence

 * health tech

 * STAT+

By Katie Palmer

Politics
Politics 1 hr ago

STAT PLUS: HOW TO TELL IF BIDEN DROVE A HARD BARGAIN ON DRUG PRICES

By John Wilkerson

Health
Health 1 hr ago


THERE’S MORE DATA FOR TRANS PEOPLE WITH HIV THAN ANY OTHER DISEASE — BUT IT’S
STILL FLAWED

By Theresa Gaffney


Health tech
Health tech 1 hr ago

STAT PLUS: DENTAL AI STARTUP RAISES $30 MILLION, INCLUDING FROM MARK
ZUCKERBERG’S DAD

By Lizzy Lawrence

First Opinion
First Opinion 1 hr ago


HOW ARTIFICIAL INTELLIGENCE CAN BOLSTER EUROPE’S COMPETITIVE EDGE IN BIOPHARMA

By Paul Hudson




MOST READ

Health


STUDY WARNS OF MORE HEART ATTACKS IF STATIN GUIDANCE SHIFTS

1 of 5 most read today

Health


LATEST COVID SURGE: NEW VARIANTS, HARD-TO-FIND TESTS, FEWER 'NOVIDS'

2 of 5 most read today

The Readout


READOUT NEWSLETTER: SAREPTA, GSK, SYNDAX, KALEO NEWS

3 of 5 most read today

In the Lab


BONE MARROW DONORS NEEDN’T BE PERFECT MATCH IN CANCER CARE: STUDY

4 of 5 most read today

Health


FOOD IS MEDICINE: MEDICAID CONTRACTORS DELIVERING SALTY, FATTY FOODS

5 of 5 most read today


MOST READ IN STAT+

Politics

STAT PLUS: TRUMP EAR INJURY: GUNSHOT TRAUMA EXPERTS OFFER GENERAL ASSESSMENT

1 of 5 most read today

Politics

STAT PLUS: J.D. VANCE HEALTH CARE POLICY VIEWS, VC INVESTMENTS

2 of 5 most read today

Biotech

STAT PLUS: FDA APPROVES GUARDANT COLORECTAL CANCER SCREENING TEST IN BIG STEP
FOR LIQUID BIOPSY

3 of 5 most read today

Exclusive

STAT PLUS: SAREPTA DEMANDED DUCHENNE ADVOCACY GROUP CENSOR VIDEO CRITICAL OF
COMPANY

4 of 5 most read today

A STAT Investigation

STAT PLUS: HEALTH CARE'S COLOSSUS: HOW UNITEDHEALTH HARNESSES ITS PHYSICIAN
EMPIRE TO SQUEEZE PROFITS OUT OF PATIENTS

5 of 5 most read today


SPONSORED

Advertisement




FIRST OPINION

 * First Opinion
   
   
   HOW ARTIFICIAL INTELLIGENCE CAN BOLSTER EUROPE’S COMPETITIVE EDGE IN
   BIOPHARMA

 * First Opinion
   
   
   MARK CUBAN’S COMPANY WON’T FIX DRUG COSTS, BUT IT CAN STILL HELP RECTIFY
   AMERICA’S DRUG SHORTAGES

 * 
 * First Opinion
   
   
   LEVERAGING SCIENTIFIC EXCELLENCE TO IMPROVE INVESTMENT DECISIONS

All First Opinion


STAT+


YOUR GO-TO SOURCE FOR THE WORLD OF LIFE SCIENCES, MEDICINE, AND BIOPHARMA.
SUBSCRIBE NOW.

Cancel anytime.

Subscribe now


TRENDING NOW

All STAT+ Stories

STAT PLUS: PHYSICIANS WEIGH IN ON POTENTIAL IMPACT OF TRUMP’S EAR WOUND: ‘IT’S A
MATTER OF INCHES’


STAT PLUS: SAREPTA DEMANDED DUCHENNE PATIENT ADVOCACY GROUP CENSOR VIDEO
CRITICAL OF THE COMPANY


STAT PLUS: WHAT TO KNOW ABOUT TRUMP VP PICK J.D. VANCE’S HEALTH CARE VIEWS AND
INVESTMENTS


STAT PLUS: HEALTH CARE'S COLOSSUS: HOW UNITEDHEALTH HARNESSES ITS PHYSICIAN
EMPIRE TO SQUEEZE PROFITS OUT OF PATIENTS


STAT PLUS: IN A BIG STEP FOR LIQUID BIOPSY, FDA APPROVES A BLOOD SCREENING TEST
FOR COLORECTAL CANCER

All STAT+ Stories
All Events

More From STAT

More From STAT

More From STAT


EVENTS

STAT offers a variety of in-person and virtual events throughout the year.

All Events

26

Sep


STAT IN DC: THE POLICY PRESCRIPTION

Washington, DC September 26, 2024

STAT in DC is back this fall. As the election nears, STAT will sit down with
lawmakers and industry leaders for a discussion on policy and its impact on our
health care system.

16

Oct


2024 STAT SUMMIT

Boston, MA

All Events
All Trackers

More From STAT

More From STAT

More From STAT


TRACKERS

We create tools to help you understand and track complex areas of development.

All Trackers


OBESITY DRUG TRACKER

Here are the dozens of weight loss drugs in development to catch a booming
market.


CRISPR TRACKER

Follow the latest developments in genome editing.


GENERATIVE AI TRACKER

A guide to the health systems and companies driving adoption.


BREAKTHROUGH DEVICE TRACKER

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT


REPORTS

STAT Reports blend data insights with qualitative observations on pivotal life
sciences topics.

All Reports


STAT’S GUIDE TO INTERPRETING CLINICAL TRIAL RESULTS

$49

Our bestselling report is now updated to help you read clinical trial results
with an appropriately skeptical (or critical) eye.


TARGETING CANCER: THE NEW FRONTIER OF IMMUNOTHERAPY AND PRECISION ONCOLOGY

A new generation of drugs is transforming the way scientists think about the
illness.


RANKING BIOTECH’S TOP VENTURE CAPITAL FIRMS

Interpreting clinical trial results is not for the faint of heart…

All Podcasts

More From STAT

More From STAT

More From STAT


PODCASTS

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts


THE READOUT LOUD

Our weekly biotech podcast digs deep into industry goings-on.


FIRST OPINION PODCAST

Our opinion podcast discusses the people, issues, and ideas that are shaping
health care.


COLOR CODE

Our podcast raising the alarm on racial inequities in American health care.

More From STAT

Events Trackers Reports Podcasts



MORE STORIES

 * Latest
 * Most Read
 * Subscriber Only
 * Opinion
 * 

In the Lab
In the Lab 14 hr ago

STAT PLUS: PARASITE ENGINEERED TO TREAT BRAIN DEVELOPMENT DISORDER IN MICE SHOWS
POTENTIAL IN STUDY

By Alia Sajani • 14 hr ago

Politics
Politics 15 hr ago


DATING APP GRINDR HIRES TOM DASCHLE’S FIRM TO LOBBY ON HIV PREVENTION, IVF

By Nicholas Florko and Sarah Owermohle • 15 hr ago

Morning Rounds
Morning Rounds 18 hr ago


MORNING ROUNDS: WOULD A BIRD FLU VACCINE FOR COWS WORK?

By Theresa Gaffney • 18 hr ago

In the Lab
In the Lab 19 hr ago


BLOOD TESTS FOR ALZHEIMER’S DIAGNOSIS WERE 91% ACCURATE IN NEW STUDY

By Associated Press • 19 hr ago

Health
Health 19 hr ago


NEW CARDIOVASCULAR RISK MODEL COULD GREATLY DECREASE USE OF STATINS AND INCREASE
HEART ATTACKS, STUDY WARNS

By Elizabeth Cooney • 19 hr ago

Biotech
Biotech 20 hr ago

STAT PLUS: IN A BIG STEP FOR LIQUID BIOPSY, FDA APPROVES A BLOOD SCREENING TEST
FOR COLORECTAL CANCER

By Matthew Herper • 20 hr ago

The Readout
The Readout 21 hr ago


THE BIOTECH NEWS YOU NEED FROM THE WEEKEND

By Meghana Keshavan • 21 hr ago

Health
Health 1 day ago


COULD COW VACCINES HELP HALT THE SPREAD OF BIRD FLU IN U.S. HERDS? EXPERTS ARE
DIVIDED

By Helen Branswell • 1 day ago


Health
Health 1 day ago


BIRD FLU SNAPSHOT: UPSTART MANUFACTURERS IN LOW- AND MIDDLE-INCOME COUNTRIES TO
START EARLY VACCINE WORK

By Helen Branswell • 1 day ago

Exclusive
Exclusive 1 day ago

STAT PLUS: SAREPTA DEMANDED DUCHENNE PATIENT ADVOCACY GROUP CENSOR VIDEO
CRITICAL OF THE COMPANY

By Adam Feuerstein • 1 day ago

Health tech
Health tech 1 day ago

STAT PLUS: DISRUPTIONS LOOM FOR TELEHEALTH PROVIDERS AND PATIENTS AS CONGRESS
INCHES CLOSER TO DEADLINE

By Mario Aguilar • 1 day ago

First Opinion
First Opinion 1 day ago


MARK CUBAN’S COMPANY WON’T FIX DRUG COSTS, BUT IT CAN STILL HELP RECTIFY
AMERICA’S DRUG SHORTAGES

By Ezekiel J. Emanuel and John Connolly • 1 day ago

First Opinion
First Opinion 1 day ago


LEVERAGING SCIENTIFIC EXCELLENCE TO IMPROVE INVESTMENT DECISIONS

By Jenny Rooke and Carolyn Bertozzi • 1 day ago

All Stories
Health
Health 5 days ago


BREAST CANCER STUDY REVEALS A PARADOX OF MASTECTOMY

By Angus Chen • 5 days ago

Health
Health 1 day ago


COULD COW VACCINES HELP HALT THE SPREAD OF BIRD FLU IN U.S. HERDS? EXPERTS ARE
DIVIDED

By Helen Branswell • 1 day ago

First Opinion
First Opinion 1 day ago


MARK CUBAN’S COMPANY WON’T FIX DRUG COSTS, BUT IT CAN STILL HELP RECTIFY
AMERICA’S DRUG SHORTAGES

By Ezekiel J. Emanuel and John Connolly • 1 day ago

Health
Health 1 day ago


BIRD FLU SNAPSHOT: UPSTART MANUFACTURERS IN LOW- AND MIDDLE-INCOME COUNTRIES TO
START EARLY VACCINE WORK

By Helen Branswell • 1 day ago

Politics
Politics 1 hr ago

STAT PLUS: HOW TO TELL IF BIDEN DROVE A HARD BARGAIN ON DRUG PRICES

By John Wilkerson • 1 hr ago

In the Lab
In the Lab 19 hr ago


BLOOD TESTS FOR ALZHEIMER’S DIAGNOSIS WERE 91% ACCURATE IN NEW STUDY

By Associated Press • 19 hr ago

Health Care Inc.
Health Care Inc. 18 hr ago

STAT PLUS: FOR-PROFIT HOSPITALS ARE GETTING A BOOST FROM A FLOOD OF PATIENTS

By Bob Herman • 18 hr ago

Pharmalot
Pharmalot 21 hr ago

STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT SAREPTA’S DEMAND TO CENSOR A VIDEO,
ROCHE FAST-TRACKING AN OBESITY PILL, AND MORE

By Ed Silverman • 21 hr ago

Pharmalot
Pharmalot 4 days ago

STAT PLUS: UP AND DOWN THE LADDER: THE LATEST COMINGS AND GOINGS

By Ed Silverman • 4 days ago

Pharmalot
Pharmalot 4 days ago

STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT A THUMBS DOWN FOR AN ALZHEIMER’S
DRUG, PFIZER GENE THERAPY STRUGGLES, AND MORE

By Ed Silverman • 4 days ago

The Readout
The Readout 4 days ago

STAT PLUS: THE WORST FOR DEXCOM MAY NOT BE OVER

By Elaine Chen • 4 days ago

Biotech
Biotech 4 days ago

STAT PLUS: EUROPEAN REGULATORS SAY ALZHEIMER’S THERAPY LEQEMBI SHOULD BE
REJECTED

By Andrew Joseph • 4 days ago

First Opinion
First Opinion 2 days ago


SURVEY: NEUROLOGISTS SPLIT ON PRESCRIBING NEW ALZHEIMER’S TREATMENTS

By P. Murali Doraiswamy and Lon S. Schneider • 2 days ago

First Opinion
First Opinion 4 days ago


SONYA MASSEY’S DEATH: HOW TO PREVENT MORE KILLINGS OF DEFENSELESS BLACK WOMEN

By Onyeka T. Otugo and Adaira I. Landry • 4 days ago

First Opinion
First Opinion 4 days ago


WITHOUT FEDERAL OVERSIGHT, NURSING HOMES WILL PUT PROFIT AHEAD OF CARE

By Melissa Batchelor and Diana J. Mason • 4 days ago

First Opinion
First Opinion 4 days ago

STAT PLUS: MEDTECH COMPLIANCE — NOT REGULATION — IS STIFLING INNOVATION

By Erez Kaminski • 4 days ago

First Opinion
First Opinion 5 days ago


SPONSORED GENETIC TESTING PROGRAMS ARE UNDER FIRE, FURTHER COMPLICATING LIFE FOR
PEOPLE WITH RARE DISEASES

By Emil D. Kakkis • 5 days ago

First Opinion
First Opinion 5 days ago


ADDING PSYCHOTHERAPY TO DRUG THERAPY WORKS, BUT THE FDA MAY NOT BE ABLE TO
HANDLE IT

By Thomas R. Insel • 5 days ago


NEWSLETTERS

Mon - Fri

Your daily dose of news in health and science

Elizabeth Cooney

Please enter a valid email address.
I'd like to be emailed about new content, events, and products.


Our Picks

Our Picks


OUR PICKS

STAT’s selection of must-read stories and investigations


WHY COVID IS SURGING THIS SUMMER — AND WHAT HEALTH EXPERTS SAY HAS CHANGED

By Elizabeth Cooney, Andrew Joseph, Rohan Rajeev, and J. Emory Parker


STAT PLUS: BROAD INSTITUTE, FACING END OF MICROSOFT CLOUD CONTRACT, SHUFFLES
DATA SCIENCE LEADERSHIP

By Megan Molteni


DESPITE BIRD FLU ANXIETY IN THE DAIRY BARN, A YEARLY TRADITION CARRIES ON AT AN
IOWA COUNTY FAIR

By Eric Boodman


STAT PLUS: WHAT TO KNOW ABOUT TRUMP VP PICK J.D. VANCE’S HEALTH CARE VIEWS AND
INVESTMENTS

By Rachel Cohrs Zhang and Sarah Owermohle


STAT PLUS: FDA INVESTIGATORS HAVE NOT SPOKEN WITH PATIENTS AND OTHERS ALLEGING
MISCONDUCT IN MDMA TRIALS

By Olivia Goldhill


STAT PLUS: TRUMP CAMPAIGN PROVIDES NEW DETAILS ON HIS EAR WOUND AND TREATMENT

By Sarah Owermohle


MASSIVE STUDY OF VETERANS’ DNA SHOWS HOW DIVERSITY CAN HELP RESEARCHERS DECIPHER
THE GENOME

By Jonathan Wosen


THE 42 BEST BOOKS AND PODCASTS ON HEALTH AND SCIENCE TO CHECK OUT THIS SUMMER

By Sarah Mupo


BIOTECH

Biotech

STAT PLUS: ROCHE CEO EXPLAINS THE COMPANY’S WEIGHT LOSS DRUG STRATEGY IN CROWDED
MARKET

By Andrew Joseph

5 days ago

By Andrew Joseph

Biotech
Biotech 5 days ago

STAT PLUS: ROCHE CEO EXPLAINS THE COMPANY’S WEIGHT LOSS DRUG STRATEGY IN CROWDED
MARKET

Biotech
Biotech 5 days ago

STAT PLUS: VIKING ACCELERATES DEVELOPMENT OF OBESITY DRUG THAT COULD RIVAL
WEGOVY, ZEPBOUND

Biotech
Biotech 6 days ago

STAT PLUS: SAGE SUFFERS PIPELINE SETBACK WITH FAILURE OF DRUG TO TREAT ESSENTIAL
TREMOR


PHARMA

Pharma

STAT PLUS: HOW PFIZER’S GRAND GENE THERAPY AMBITIONS CRUMBLED

By Jason Mast

4 days ago

By Jason Mast

Pharma
Pharma 4 days ago

STAT PLUS: HOW PFIZER’S GRAND GENE THERAPY AMBITIONS CRUMBLED

Pharmalot
Pharmalot 5 days ago

STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT A VIKING OBESITY DRUG, BAUSCH
HEALTH’S BANKRUPTCY DENIAL, AND MORE

Pharmalot
Pharmalot 6 days ago

STAT PLUS: PHARMALITTLE: WE’RE READING ABOUT A CVS DEAL WITH ILLINOIS, A PFIZER
HEMOPHILIA THERAPY, AND MORE


HEALTH

Health


HOSPITALS, LABS, AND HEALTH DEPARTMENTS TRY TO COPE WITH BLOOD CULTURE BOTTLE
SHORTAGE

By Helen Branswell

6 days ago

By Helen Branswell

Health
Health 6 days ago


HOSPITALS, LABS, AND HEALTH DEPARTMENTS TRY TO COPE WITH BLOOD CULTURE BOTTLE
SHORTAGE

Health
Health 1 week ago


VA DISPUTES CLAIM THAT REMOVING RACE FROM LUNG TESTS WOULD GREATLY ALTER
DISABILITY PAYMENTS

Health
Health 1 week ago


Q&A: TRANS ADULTS FACE ‘SHOCKING’ RISK OF CIRRHOSIS, ESPECIALLY ALCOHOL-DRIVEN


POLITICS

Politics

STAT PLUS: KAMALA HARRIS’ VIEWS ON HEALTH CARE WERE SHAPED BY HER MOTHER, CANCER
RESEARCHER SHYAMALA GOPALAN

By Rohan Rajeev

4 days ago

By Rohan Rajeev

Politics
Politics 4 days ago

STAT PLUS: KAMALA HARRIS’ VIEWS ON HEALTH CARE WERE SHAPED BY HER MOTHER, CANCER
RESEARCHER SHYAMALA GOPALAN

Politics
Politics 5 days ago

STAT PLUS: POWERFUL SENATE COMMITTEE DEMANDS TESTIMONY FROM CEO OF BANKRUPT
STEWARD HOSPITAL CHAIN

Politics
Politics 5 days ago

STAT PLUS: A NEUROLOGICAL DISORDER STOLE HER VOICE. JENNIFER WEXTON TAKES IT
BACK ON THE HOUSE FLOOR


VIDEO

Video


HOW INSURERS USE DOCTORS TO PROFIT OFF MEDICAL CODES

Video


STAT PLUS: HOW PHARMACY BENEFIT MANAGERS INFLUENCE DRUG PRICING

Video


STAT PLUS: THE ROLE OF PBMS, PATENTS, AND PUBLIC HEALTH IN DRUG PRICING

In the Lab


STAT PLUS: HOW HARVARD RESEARCHERS BOOSTED AN ALS PATIENT’S INDEPENDENCE WITH A
BOX AND A BALLOON

All Videos

Covid-19

Covid-19

I think people have to understand that we’re probably going to be dealing with
Covid for many, many, many years to come. There will be waxing and waning of
infections, summer or winter.Read the story

— Aaron Glatt, chair and professor of medicine at Mount Sinai South Nassau

Covid-19


HEALTH TECH

Health tech

STAT PLUS: SIX QUESTIONS ABOUT MEDICARE’S PROPOSED PLAN TO COVER DIGITAL
THERAPEUTICS

By Mario Aguilar

5 days ago

By Mario Aguilar

Health tech
Health tech 5 days ago

STAT PLUS: SIX QUESTIONS ABOUT MEDICARE’S PROPOSED PLAN TO COVER DIGITAL
THERAPEUTICS

Health tech
Health tech 5 days ago

STAT PLUS: FEDERAL REGULATION OF HEALTH DATA AND AI EXPECTED TO GET A BOOST
AFTER HHS REVAMP

Health tech
Health tech 6 days ago

STAT PLUS: ROBOTIC AID HELPED IMPROVE BALANCE, GAIT IN CHILDREN WITH CEREBRAL
PALSY


IN THE LAB

In the Lab


AT A MASS GENERAL PERFUSION LAB, A PUSH TO MAKE MORE AND MORE HEARTS VIABLE FOR
TRANSPLANT

By Deborah Balthazar

1 week ago

By Deborah Balthazar

In the Lab
In the Lab 1 week ago


AT A MASS GENERAL PERFUSION LAB, A PUSH TO MAKE MORE AND MORE HEARTS VIABLE FOR
TRANSPLANT

In the Lab
In the Lab 3 weeks ago


EXPANSIVE NEW STUDY POINTS TO DISTINCT BRAIN NETWORKS LINKED TO SEX AND GENDER

In the Lab
In the Lab 3 weeks ago


CAR-T CELL THERAPY’S COMPLICATIONS, AS WELL AS ITS BENEFITS, BECOME CLEARER IN
‘FLURRY’ OF CANCER STUDIES


HOSPITALS

Hospitals

STAT PLUS: SANFORD HEALTH AIMS TO SHAKE OFF A RUN OF FAILED DEALS BY SNAPPING UP
A $3 BILLION WISCONSIN HEALTH SYSTEM

By Tara Bannow

3 weeks ago

By Tara Bannow

Hospitals
Hospitals 3 weeks ago

STAT PLUS: SANFORD HEALTH AIMS TO SHAKE OFF A RUN OF FAILED DEALS BY SNAPPING UP
A $3 BILLION WISCONSIN HEALTH SYSTEM

Hospitals
Hospitals 4 weeks ago

STAT PLUS: FORMER MASS GENERAL PRESIDENT PETER SLAVIN WILL RUN CEDARS-SINAI IN
LOS ANGELES

Hospitals
Hospitals 1 month ago


STEWARD HEALTH CARE SPENT MILLIONS ON SURVEILLANCE OF ITS CRITICS — EVEN AMID
FINANCIAL CRISIS


INSURANCE

Insurance

STAT PLUS: NEW MEDICARE ADVANTAGE STAR RATINGS GIVE EXTRA BONUSES TO MULTIPLE
INSURERS

By Bob Herman

4 weeks ago

By Bob Herman

Insurance
Insurance 4 weeks ago

STAT PLUS: NEW MEDICARE ADVANTAGE STAR RATINGS GIVE EXTRA BONUSES TO MULTIPLE
INSURERS

Insurance
Insurance 2 months ago

STAT PLUS: APPEALS COURT OVERTURNS SUTTER HEALTH’S VICTORY IN $400 MILLION
ANTITRUST CASE

Insurance
Insurance 2 months ago


UNITEDHEALTH ARGUES ALGORITHM LAWSUIT SHOULD BE DISMISSED BECAUSE PATIENTS
DIDN’T SPEND YEARS APPEALING DENIALS


PODCASTS

The Readout LOUD


STAT PLUS: UNITEDHEALTH’S DOCTOR EMPIRE, AN FDA DEPARTURE, AND VIKING’S OBESITY
MOVES

The Readout LOUD


JD VANCE’S BIOTECH TIES, CASSAVA RESIGNATIONS, AND INSULIN SHORTAGES

First Opinion Podcast


EMPATHY SHOULD BE THE FIRST RESPONSE TO PEOPLE WITH VACCINE INJURY, FEARS

The Readout LOUD


BIOTECH LAYOFFS, FOUNDER-FOCUSED VC, & A BIG PHARMA EXIT

All Podcasts

Sign up for our morning rounds newsletter




Reporting from the frontiers of health and medicine

Back to top

Company

 * About
 * Our Team
 * Contact Us
 * Careers
 * Diversity & Inclusion
 * Our Awards
 * Advertise With Us
 * STAT Brand Studio
 * Supporters
 * Licensing Stories

Account

 * STAT+
 * Group Subscriptions
 * FAQ
 * My Account
 * Log In
 * Subscribe

More

 * Events
 * Newsletters
 * Reports
 * App
 * Podcasts
 * Community

 * Privacy
 * Comment Policy
 * Terms
 * Do Not Sell My Data
 * ©2024 STAT

 * 
 * 
 * 
 * 
 * 
 * 
 * 







STAT NEWS ASKS FOR YOUR CONSENT TO USE YOUR PERSONAL DATA TO:

 * show_chart
   Personalised advertising, advertising and content measurement, audience
   research and services development
 * perm_identity
   Personalised content
 * devices
   Store and/or access information on a device

expand_moreremove
Learn more
 * 
   How can I change my choice?
 * 
   What if I don't consent?
 * 
   How does legitimate interest work?
 * 
   Do I have to consent to everything?

Your personal data will be processed and information from your device (cookies,
unique identifiers, and other device data) may be stored by, accessed by and
shared with 9 TCF vendor(s) and 1 ad partner(s), or used specifically by this
site or app.

Some vendors may process your personal data on the basis of legitimate interest,
which you can object to by managing your options below. Look for a link at the
bottom of this page to manage or withdraw consent in privacy and cookie
settings.

Consent



Manage options

arrow_back

Data preferences


MANAGE YOUR DATA

You can choose how your personal data is used. Vendors want your permission to
do the following:

TCF vendors

help_outline


STORE AND/OR ACCESS INFORMATION ON A DEVICE

Cookies, device or similar online identifiers (e.g. login-based identifiers,
randomly assigned identifiers, network based identifiers) together with other
information (e.g. browser type and information, language, screen size, supported
technologies etc.) can be stored or read on your device to recognise it each
time it connects to an app or to a website, for one or several of the purposes
presented here.

View details
Consent (8 vendors)


USE LIMITED DATA TO SELECT ADVERTISING

Advertising presented to you on this service can be based on limited data, such
as the website or app you are using, your non-precise location, your device type
or which content you are (or have been) interacting with (for example, to limit
the number of times an ad is presented to you).

View details
Consent (1 vendor)Legitimate interest (1 vendor)help_outline


CREATE PROFILES FOR PERSONALISED ADVERTISING

Information about your activity on this service (such as forms you submit,
content you look at) can be stored and combined with other information about you
(for example, information from your previous activity on this service and other
websites or apps) or similar users. This is then used to build or improve a
profile about you (that might include possible interests and personal aspects).
Your profile can be used (also later) to present advertising that appears more
relevant based on your possible interests by this and other entities.

View details
Consent (7 vendors)


USE PROFILES TO SELECT PERSONALISED ADVERTISING

Advertising presented to you on this service can be based on your advertising
profiles, which can reflect your activity on this service or other websites or
apps (like the forms you submit, content you look at), possible interests and
personal aspects.

View details
Consent (2 vendors)


CREATE PROFILES TO PERSONALISE CONTENT

Information about your activity on this service (for instance, forms you submit,
non-advertising content you look at) can be stored and combined with other
information about you (such as your previous activity on this service or other
websites or apps) or similar users. This is then used to build or improve a
profile about you (which might for example include possible interests and
personal aspects). Your profile can be used (also later) to present content that
appears more relevant based on your possible interests, such as by adapting the
order in which content is shown to you, so that it is even easier for you to
find content that matches your interests.

View details
Consent (5 vendors)


USE PROFILES TO SELECT PERSONALISED CONTENT

Content presented to you on this service can be based on your content
personalisation profiles, which can reflect your activity on this or other
services (for instance, the forms you submit, content you look at), possible
interests and personal aspects. This can for example be used to adapt the order
in which content is shown to you, so that it is even easier for you to find
(non-advertising) content that matches your interests.

View details
Consent (1 vendor)


MEASURE ADVERTISING PERFORMANCE

Information regarding which advertising is presented to you and how you interact
with it can be used to determine how well an advert has worked for you or other
users and whether the goals of the advertising were reached. For instance,
whether you saw an ad, whether you clicked on it, whether it led you to buy a
product or visit a website, etc. This is very helpful to understand the
relevance of advertising campaigns.

View details
Consent (3 vendors)Legitimate interest (3 vendors)help_outline


MEASURE CONTENT PERFORMANCE

Information regarding which content is presented to you and how you interact
with it can be used to determine whether the (non-advertising) content e.g.
reached its intended audience and matched your interests. For instance, whether
you read an article, watch a video, listen to a podcast or look at a product
description, how long you spent on this service and the web pages you visit etc.
This is very helpful to understand the relevance of (non-advertising) content
that is shown to you.

View details
Consent (2 vendors)Legitimate interest (1 vendor)help_outline


UNDERSTAND AUDIENCES THROUGH STATISTICS OR COMBINATIONS OF DATA FROM DIFFERENT
SOURCES

Reports can be generated based on the combination of data sets (like user
profiles, statistics, market research, analytics data) regarding your
interactions and those of other users with advertising or (non-advertising)
content to identify common characteristics (for instance, to determine which
target audiences are more receptive to an ad campaign or to certain contents).

View details
Consent (5 vendors)Legitimate interest (2 vendors)help_outline


DEVELOP AND IMPROVE SERVICES

Information about your activity on this service, such as your interaction with
ads or content, can be very helpful to improve products and services and to
build new products and services based on user interactions, the type of
audience, etc. This specific purpose does not include the development or
improvement of user profiles and identifiers.

View details
Consent (4 vendors)Legitimate interest (3 vendors)help_outline


ENSURE SECURITY, PREVENT AND DETECT FRAUD, AND FIX ERRORS

help_outline

Your data can be used to monitor for and prevent unusual and possibly fraudulent
activity (for example, regarding advertising, ad clicks by bots), and ensure
systems and processes work properly and securely. It can also be used to correct
any problems you, the publisher or the advertiser may encounter in the delivery
of content and ads and in your interaction with them.

View details


DELIVER AND PRESENT ADVERTISING AND CONTENT

help_outline

Certain information (like an IP address or device capabilities) is used to
ensure the technical compatibility of the content or advertising, and to
facilitate the transmission of the content or ad to your device.

View details


SAVE AND COMMUNICATE PRIVACY CHOICES

help_outline

The choices you make regarding the purposes and entities listed in this notice
are saved and made available to those entities in the form of digital signals
(such as a string of characters). This is necessary in order to enable both this
service and those entities to respect such choices.

View details


MATCH AND COMBINE DATA FROM OTHER DATA SOURCES

help_outline

Information about your activity on this service may be matched and combined with
other information relating to you and originating from various sources (for
instance your activity on a separate online service, your use of a loyalty card
in-store, or your answers to a survey), in support of the purposes explained in
this notice.

View details


LINK DIFFERENT DEVICES

help_outline

In support of the purposes explained in this notice, your device might be
considered as likely linked to other devices that belong to you or your
household (for instance because you are logged in to the same service on both
your phone and your computer, or because you may use the same Internet
connection on both devices).

View details


IDENTIFY DEVICES BASED ON INFORMATION TRANSMITTED AUTOMATICALLY

help_outline

Your device might be distinguished from other devices based on information it
automatically sends when accessing the Internet (for instance, the IP address of
your Internet connection or the type of browser you are using) in support of the
purposes exposed in this notice.

View details

Vendor preferences

Accept all



Confirm choices

arrow_back

Vendor preferences


CONFIRM OUR VENDORS

Vendors can use your data to provide services. Declining a vendor can stop them
from using the data you shared.

TCF vendors

help_outline


SHARETHIS, INC

Cookie duration: 390 (days).

Data collected and processed: Non-precise location data, IP addresses,
Probabilistic identifiers, Browsing and interaction data, Device identifiers,
Device characteristics, Users’ profiles, Privacy choices

more




View details | Privacy policylaunch
Consent


LOTAME SOLUTIONS, INC

Cookie duration: 274 (days).

Data collected and processed: IP addresses, Probabilistic identifiers, Browsing
and interaction data, User-provided data, Device identifiers, Device
characteristics, Authentication-derived identifiers, Users’ profiles, Privacy
choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Privacy policylaunch
Consent


LIVERAMP

Cookie duration: 365 (days).

Data collected and processed: Non-precise location data, IP addresses, Browsing
and interaction data, Device identifiers, Device characteristics,
Authentication-derived identifiers, Privacy choices

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policylaunch
Consent


DYNATA LLC

Cookie duration: 365 (days).

Data collected and processed: Non-precise location data, IP addresses, Browsing
and interaction data, User-provided data, Device identifiers, Device
characteristics, Authentication-derived identifiers, Users’ profiles, Privacy
choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policylaunch
Consent


EYEOTA PTE LTD

Cookie duration: 366 (days).

Data collected and processed: Non-precise location data, IP addresses,
Probabilistic identifiers, Device identifiers, Device characteristics, Users’
profiles, Privacy choices

more

Cookie duration resets each session.


View details | Storage details | Privacy policylaunch
Consent


BOMBORA INC.

Cookie duration: 365 (days).

Data collected and processed: Non-precise location data, IP addresses, Browsing
and interaction data, Device identifiers, Device characteristics,
Authentication-derived identifiers, Users’ profiles

more

Cookie duration resets each session. Uses other forms of storage.


View details | Storage details | Privacy policylaunch
ConsentLegitimate interesthelp_outline


ORACLE ADVERTISING

Cookie duration: 180 (days).

Data collected and processed: Non-precise location data, IP addresses, Browsing
and interaction data, User-provided data, Device identifiers, Device
characteristics, Authentication-derived identifiers, Users’ profiles, Privacy
choices

more

Uses other forms of storage.


View details | Storage details | Privacy policylaunch
Consent


GOOGLE ADVERTISING PRODUCTS

Cookie duration: 396 (days).

Data collected and processed: Non-precise location data, IP addresses, Browsing
and interaction data, User-provided data, Device identifiers, Device
characteristics, Authentication-derived identifiers, Users’ profiles, Privacy
choices

more

Uses other forms of storage.


View details | Storage details | Privacy policylaunch
ConsentLegitimate interesthelp_outline


ORACLE DATA CLOUD - MOAT

Doesn't use cookies.

Data collected and processed: Non-precise location data, IP addresses

more




View details | Privacy policylaunch
Legitimate interesthelp_outline

Ad partners

help_outline


ADSTRA

Privacy policylaunch
Consent

Accept all



Confirm choices

Close

Please review our cookie policy

We use first- and third-party cookies to customize your experience and display
advertising. By continuing to use the site, you agree to our use of cookies. If
you want to know more or opt out in whole or in part, please see our Privacy
Notice and our Cookie FAQ.

Accept No thanks